Dominant negative pleiotrophin induces tetraploidy and aneuploidy in U87MG human glioblastoma cells.
Pleiotrophin (PTN, Ptn) is an 18kDa secretory cytokine that is expressed in many human cancers, including glioblastoma. In previous experiments, interruption of the constitutive PTN signaling in human U87MG glioblastoma cells that inappropriately express endogenous Ptn reversed their rapid growth in vitro and their malignant phenotype in vivo. To seek a mechanism for the effect of the dominant-negative PTN, flow cytometry was used to compare the profiles of U87MG cells and four clones of U87MG cells that express the dominant-negative PTN (U87MG/PTN1-40 cells); here, we report that the dominant-negative PTN in U87MG cells induces tetraploidy and aneuploidy and arrests the tetraploid and aneuploid cells in the G1 phase of the cell cycle. The data suggest that PTN signaling may have a critical role in chromosomal segregation and cell cycle progression; the data suggest induction of tetraploidy and aneuploidy in U87MG glioblastoma cells may be an important mechanism that contributes to the loss of the malignant phenotype of U87MG cells.
Chang
Yunchao
Y
Department of Molecular and Experimental Medicine, the Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037, USA.
Berenson
James R
JR
Wang
Zhaoyi
Z
Deuel
Thomas F
TF
D000782:Aneuploidy; D002352:Carrier Proteins / Q000502:physiology*; D002453:Cell Cycle / Q000502:physiology*; D045744:Cell Line, Tumor; D003001:Cloning, Molecular; D016207:Cytokines / Q000502:physiology*; D005434:Flow Cytometry; D016193:G1 Phase / Q000502:physiology; D005909:Glioblastoma; D006801:Humans; D009154:Mutation; D011123:Polyploidy
D002352:Carrier Proteins; D016207:Cytokines; C066845:pleiotrophin